Se. Bucklin et al., AN INTERLEUKIN-6-INDUCED ACUTE-PHASE RESPONSE DOES NOT CONFER PROTECTION AGAINST LIPOPOLYSACCHARIDE LETHALITY, Infection and immunity, 61(8), 1993, pp. 3184-3189
Lipopolysaccharide (LPS), a component of gram-negative bacterial outer
cell walls, can stimulate lymphoreticular cells to produce cytokines
such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 (IL-1),
and IL-6. One of these proinflammatory cytokines, IL-6, induces hepat
ic synthesis of a class of proteins termed acute-phase proteins. D-Gal
actosamine inhibits acute-phase protein synthesis and concurrently sen
sitizes mice to a lethal dose of LPS approximately 10,000-fold. From t
hese observations, we hypothesized that the acute-phase response may s
erve as a defense mechanism for protection of the host against the del
eterious effects of LPS. To test this hypothesis, murine recombinant I
L-6 (mrIL-6) was used to induce an acute-phase response prior to a let
hal LPS challenge in both D-galactosamine-treated and normal mice. Ind
uction of the acute-phase response by mrIL-6 was quantitated by measur
ing the concentrations of fibrinogen and complement component C3, two
well-characterized acute-phase proteins, in the circulation. The effec
t of acute-phase and normal serum on TNF-alpha release by peritoneal m
acrophages stimulated with LPS in vitro was also examined. The results
of these studies confirmed the induction of the acute-phase response
by mrIL-6, as reflected in an approximate doubling in circulating leve
ls of fibrinogen and C3. However, when either D-galactosamine-sensitiz
ed or normal mice were challenged with a lethal dose of LPS at various
times after mrIL-6 administration, the acute-phase response induced b
y mrIL-6 did not alter either cumulative lethality or the kinetics of
lethality. Additionally, compared with normal serum, acute-phase serum
did not affect TNF-alpha release by peritoneal macrophages following
LPS-mediated stimulation in vitro. Collectively, these studies would n
ot support a dominant role for an IL-6-mediated acute-phase response a
s contributing to the resistance of normal mice compared with D-galact
osamine-sensitized mice in LPS-induced lethal toxicity.